276 related articles for article (PubMed ID: 33345447)
1. Exosome-derived long non-coding RNA ADAMTS9-AS2 suppresses progression of oral submucous fibrosis via AKT signalling pathway.
Zhou S; Zhu Y; Li Z; Zhu Y; He Z; Zhang C
J Cell Mol Med; 2021 Feb; 25(4):2262-2273. PubMed ID: 33345447
[TBL] [Abstract][Full Text] [Related]
2. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway.
Wang J; Jiang C; Li N; Wang F; Xu Y; Shen Z; Yang L; Li Z; He C
Cell Death Dis; 2020 Aug; 11(8):682. PubMed ID: 32826876
[TBL] [Abstract][Full Text] [Related]
3. LncRNA ADAMTS9-AS2 promotes tongue squamous cell carcinoma proliferation, migration and EMT via the miR-600/EZH2 axis.
Li Y; Wan Q; Wang W; Mai L; Sha L; Mashrah M; Lin Z; Pan C
Biomed Pharmacother; 2019 Apr; 112():108719. PubMed ID: 30970517
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of lncRNA ADAMTS9-AS2 Promotes Salivary Adenoid Cystic Carcinoma Metastasis via PI3K/Akt and MEK/Erk Signaling.
Xie S; Yu X; Li Y; Ma H; Fan S; Chen W; Pan G; Wang W; Zhang H; Li J; Lin Z
Mol Ther; 2018 Dec; 26(12):2766-2778. PubMed ID: 30217729
[TBL] [Abstract][Full Text] [Related]
5. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway.
Wang A; Jin C; Li H; Qin Q; Li L
Int J Biol Macromol; 2018 Dec; 120(Pt B):1705-1713. PubMed ID: 30268751
[TBL] [Abstract][Full Text] [Related]
6. ADAMTS9-AS2: A Functional Long Non-coding RNA in Tumorigenesis.
Xu W; Wang B; Cai Y; Chen J; Lv X; Guo C; Yuan C
Curr Pharm Des; 2021; 27(23):2722-2727. PubMed ID: 33823762
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA ADAMTS9-AS1 suppresses colorectal cancer by inhibiting the Wnt/β-catenin signalling pathway and is a potential diagnostic biomarker.
Li N; Li J; Mi Q; Xie Y; Li P; Wang L; Binang H; Wang Q; Wang Y; Chen Y; Wang Y; Mao H; Du L; Wang C
J Cell Mol Med; 2020 Oct; 24(19):11318-11329. PubMed ID: 32889785
[TBL] [Abstract][Full Text] [Related]
8. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis.
Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C
Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791
[TBL] [Abstract][Full Text] [Related]
9. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
[TBL] [Abstract][Full Text] [Related]
10. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3.
Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T
IUBMB Life; 2018 Jun; 70(6):536-546. PubMed ID: 29707897
[TBL] [Abstract][Full Text] [Related]
11. Low LINC02147 expression promotes the malignant progression of oral submucous fibrosis.
Chen J; Li W; Liu B; Xie X
BMC Oral Health; 2022 Jul; 22(1):316. PubMed ID: 35906577
[TBL] [Abstract][Full Text] [Related]
12. Expression pattern of DKK3, dickkopf WNT signaling pathway inhibitor 3, in the malignant progression of oral submucous fibrosis.
Zhou S; Zhu Y; Mashrah M; Zhang X; He Z; Yao Z; Zhang C; Guo F; Hu Y; Zhang C
Oncol Rep; 2017 Feb; 37(2):979-985. PubMed ID: 27959428
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
Zhang X; Niu W; Mu M; Hu S; Niu C
J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
[TBL] [Abstract][Full Text] [Related]
14. RETRACTED: Down-regulation of lncRNA ADAMTS9-AS2 contributes to gastric cancer development via activation of PI3K/Akt pathway.
Cao B; Liu C; Yang G
Biomed Pharmacother; 2018 Nov; 107():185-193. PubMed ID: 30089248
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA ADAMTS9-AS2 suppresses the progression of esophageal cancer by mediating CDH3 promoter methylation.
Liu D; Wu K; Yang Y; Zhu D; Zhang C; Zhao S
Mol Carcinog; 2020 Jan; 59(1):32-44. PubMed ID: 31621118
[TBL] [Abstract][Full Text] [Related]
16. ADAMTS9-AS2 regulates PPP1R12B by adsorbing miR-196b-5p and affects cell cycle-related signaling pathways inhibiting the malignant process of esophageal cancer.
Chen Z; Tang W; Ye W; Song L; Chen Z
Cell Cycle; 2022 Aug; 21(16):1710-1725. PubMed ID: 35503407
[TBL] [Abstract][Full Text] [Related]
17. Melittin inhibits the proliferation migration and invasion of HCC cells by regulating ADAMTS9-AS2 demethylation.
Lv C; Chen J; Huang F; Fang F; Li B
Toxicon; 2023 Jan; 222():106996. PubMed ID: 36535531
[TBL] [Abstract][Full Text] [Related]
18. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis.
Ren N; Jiang T; Wang C; Xie S; Xing Y; Piao D; Zhang T; Zhu Y
Aging (Albany NY); 2020 Jun; 12(11):11025-11041. PubMed ID: 32516127
[TBL] [Abstract][Full Text] [Related]
19. [Overexpression of the long non-coding RNA ADAMTS9-AS2 suppresses colorectal cancer proliferation and metastasis].
Bu X; Qin A; Luo Z; Hu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 44(7):741-748. PubMed ID: 31413211
[TBL] [Abstract][Full Text] [Related]
20. Long-Chain Noncoding RNA ADAMTS9-AS2 Regulates Proliferation, Migration, and Apoptosis in Bladder Cancer Cells Through Regulating miR-182-5p.
Guo Q; Ni P; Dai Y; Hu J; Yao Y
J Interferon Cytokine Res; 2021 Feb; 41(2):60-71. PubMed ID: 33621133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]